Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela J Yoon

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Molecular Cell|October 7, 2022
Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomasYinglu Li, Elizabeth M Goldberg, Xiao Chen, et al.
Journal of Oncology|January 29, 2021
MicroRNA-Based Cancer Mortality Risk Scoring System and hTERT Expression in Early-Stage Oral Squamous Cell CarcinomaAngela J Yoon, Regina M Santella, Shuang Wang, et al.
Biomarker Research|June 6, 2021
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinomaChi T Viet, Gary Yu, Kesava Asam, et al.
Current Protocols in Stem Cell Biology|April 16, 2020
Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer OrganoidsTatiana A Karakasheva, Takashi Kijima, Masataka Shimonosono, et al.
Frontiers in Immunology|February 11, 2025
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinomaAngela J Yoon, Richard D Carvajal, Evan M Graboyes, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Molecular Cell|October 7, 2022
Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomasYinglu Li, Elizabeth M Goldberg, Xiao Chen, et al.
Journal of Oncology|January 29, 2021
MicroRNA-Based Cancer Mortality Risk Scoring System and hTERT Expression in Early-Stage Oral Squamous Cell CarcinomaAngela J Yoon, Regina M Santella, Shuang Wang, et al.
Biomarker Research|June 6, 2021
The REASON score: an epigenetic and clinicopathologic score to predict risk of poor survival in patients with early stage oral squamous cell carcinomaChi T Viet, Gary Yu, Kesava Asam, et al.
Current Protocols in Stem Cell Biology|April 16, 2020
Generation and Characterization of Patient-Derived Head and Neck, Oral, and Esophageal Cancer OrganoidsTatiana A Karakasheva, Takashi Kijima, Masataka Shimonosono, et al.
Frontiers in Immunology|February 11, 2025
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinomaAngela J Yoon, Richard D Carvajal, Evan M Graboyes, et al.
Pageof 5